The first oral antiviral drug, favipiravir 200 mg, was introduced by Glenmark Pharmaceutical under the trade name FaviFlu to treat mild to severe COVID-19 cases. In global clinical trials, this medication has demonstrated 80–88% efficacy. It is presently being used in Japan and the United Arab Emirates to treat COVID-19.
The Indian drug regulator authorized the oral consumption of Faviflu on June 19, 2020.
Oral administration of favipiravir is recommended at around the same time every day, with or without food. Tablets containing favipiravir should be taken whole with water. It is not recommended to chew, break, or open the tablet. Adult COVID-19 patients typically receive 1800 mg of favipiravir orally twice a day on day 1, then 800 mg of the same medication twice a day for the next 14 days.
The Fabiflu frequently causes gastrointestinal distress, asthma attacks, hay fever, allergic dermatitis, edema throughout the body, and miscarriages.
Because favipiravir may harm the fetus, its usage during pregnancy is restricted.
When favipiravir is tested in animals, it primarily results in early embryonic demise. Pregnant women should not take this drug as recommended.
During therapy, the most effective method of contraception should be used. Treatment must end right away if pregnancy develops.
When a bacterial infection occurs, avigan is not prescribed.
For kids, favipiravir is not advised.
If the patient has a history of hypersensitivity to any of the product’s constituents, they should not use this medication.
You should only take this medication when you have symptoms similar to the flu.
An examination ought to be conducted to determine whether Favipiravir is required prior to use.
Favipiravir is highly likely to be distributed in sperm. When giving this drug to individuals that are male. Explain all the risks in detail and give instructions not to have sex for seven days following the conclusion of the treatment.
What applications does Favipiravir have?
An antiviral drug called favipiravir combats both type A and type B influenza viruses. The mild to severe Covid-19 infection is treated with it. It prevents influenza A and B from replicating.
What components make up Favipiravir?
Favipiravir is the active ingredient; povidone, colloidal silicon dioxide, crospovidone, low-substituted hydroxypropyl cellulose, sodium stearyl fumarate, hypromellose, titanium dioxide, talc, and yellow ferric oxide are the inactive ingredients.
How should Favipiravir medication be stored?
The Favipiravir tablets should be kept at room temperature.
The Indian Generic Medicines is a Consultancy and Service company providing access to genuine generic medicines to patients all across the world. We also have own pharmacy named as Indian Generic Medicines which work under compliant distribution guidelines.
© 2024 Indian Generic Medicines. All rights reserved.
